Aviram Mizrachi, MD, FACS
Aviram Mizrachi, MD, FACS
Treats Children
Locations and Appointments
Please contact the doctor's office to verify that your insurance is accepted.
*Indicates this doctor is no longer accepting new patients with this insurance plan.
- HMO
- Medicare
- PPO
- EPO/POS
- CHP
- Blue Access
- Blue Connection
- EPO
- HMO
- Mediblue (Senior)
- PPO
- CBP
- Medicare
- Freedom
- Liberty
- Medicare Advantage
- Metro/Core/Charter
- Community Plan
- Medicare
- HMO
- Medicare
About Aviram Mizrachi, MD, FACS
Dr. Mizrachi specializes in the diagnosis and treatment of head and neck tumors and cancer. His expertise focuses on surgery for both benign and malignant tumors of the head and neck region, including Tongue, Lip, and Oral Cancer, Thyroid and Parathyroid Tumors, Salivary Gland Tumors, Throat Cancer (Larynx), Oropharyngeal Cancer (HPV+) and Melanoma and Skin Cancer.
Dr. Mizrachi is an Associate Professor in the Department of Otolaryngology-Head and Neck Surgery at Â鶹¸ßÇå. He dedicates all his time to patient care, research, and training of residents and medical students.
If you are scheduled to see Dr. Mizrachi as a new patient, please print and complete the and bring it with you on the day of your appointment. Thank you.
Dr. Mizrachi received his medical degree from the Hebrew University and Hadassah Medical School in Jerusalem and then completed a residency in Otolaryngology-Head and Neck Surgery at Rabin Medical Center, a leading tertiary care center in Israel, which is also the largest cancer center in the country serving a population of approximately 4.5 million people. Following that, Dr. Mizrachi pursued advanced training in head and neck oncologic surgery and translational research at Memorial Sloan-Kettering Cancer Center in New York.
After completing his fellowship, Dr. Mizrachi returned to Rabin Medical Center and practiced there as a full-time surgeon-scientist for 8 years before moving back to NY.
Dr. Mizrachi’s research portfolio focuses on precision oncology, investigating tumor and radiation biology and immunology as well as targeted drug delivery for Head and Neck Cancer and Skin Cancer.
Dr. Mizrachi is a member of the American Association for Cancer Research, American Head and Neck Society, International Federation of Head and Neck Oncologic Societies, and the American College of Surgeons. He is the author of over 85 peer-reviewed publications and is often invited to speak at national and international professional meetings.
- Outstanding Resident Award, Rabin Medical Center, Israel, 2013
- Board Exams Excellence Award, Israeli Board of Otolaryngology-Head and Neck Surgery, 2014
- Outstanding Teaching Award, Faculty of Medical & Health Sciences, Tel Aviv University, Israel, 2021
- Chief of the Head and Neck Oncologic Surgery Service, Department of Otolaryngology-Head and Neck Surgery, Rabin Medical Center, Israel, 2019-2024
- Scientific Secretary of the Israeli Society of Head & Neck Surgery and Oncology, 2021-2024
- Director of the Continuous Medical Education Program in Otolaryngology-Head and Neck Surgery, Faculty of Medical & Health Sciences, Tel Aviv University, Israel, 2020-2024
- Special Contribution Award, Israeli Board of Otolaryngology-Head and Neck Surgery, 2024
-
M.D.Hadassah Medical School, The Hebrew University (Israel)2008
-
B.Med.Sc.Hadassah Medical School, The Hebrew University (Israel)2004
-
Associate Attending OtolaryngologistNewYork-Presbyterian Hospital
-
Associate Professor of Otolaryngology (Pending Appointment at Rank)Weill Cornell Medical College, Cornell University
External Relationships
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
No External Relationships Reported